Alnylam Pharmaceuticals shares owned by Morgan Stanley
Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Morgan Stanley
from 13F filings
Historical chart of Morgan Stanley investment in Alnylam Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Alnylam Pharmaceuticals held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Alnylam Pharmaceuticals by Morgan Stanley
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $182M | 742k | 245.15 |
| 2024-03-31 | $102M | 675k | 150.65 |
| 2023-12-31 | $157M | 807k | 194.32 |
| 2023-09-30 | $214M | 1.2M | 177.10 |
| 2023-06-30 | $357M | 1.9M | 189.94 |
| 2022-12-31 | $331M | 1.4M | 237.65 |
| 2022-06-30 | $161M | 1.1M | 142.86 |
| 2022-03-31 | $140M | 849k | 164.52 |
| 2021-06-30 | $320M | 1.9M | 169.81 |
| 2020-12-31 | $0 | 1.7M | 0.00 |
| 2020-09-30 | $222M | 1.5M | 145.99 |
| 2020-06-30 | $224M | 1.5M | 148.10 |
| 2020-03-31 | $151M | 1.4M | 108.87 |
| 2019-12-31 | $178M | 1.5M | 115.17 |
| 2019-09-30 | $110M | 1.4M | 80.42 |
| 2019-03-31 | $119M | 1.2M | 97.56 |
| 2018-12-31 | $86M | 1.2M | 72.91 |
| 2018-09-30 | $108M | 1.2M | 87.51 |
| 2018-06-30 | $124M | 1.3M | 98.49 |
| 2018-03-31 | $150M | 1.3M | 119.13 |
| 2017-12-31 | $149M | 1.2M | 127.06 |
| 2017-03-31 | $36M | 702k | 51.25 |
| 2016-12-31 | $30M | 812k | 37.45 |
| 2016-09-30 | $57M | 840k | 67.80 |
| 2016-06-30 | $49M | 875k | 55.46 |
| 2016-03-31 | $68M | 1.1M | 62.75 |
| 2015-12-31 | $103M | 1.1M | 94.08 |
| 2015-09-30 | $97M | 1.2M | 80.33 |
| 2015-06-30 | $156M | 1.3M | 119.84 |
| 2014-12-31 | $134M | 1.4M | 97.07 |
| 2014-09-30 | $67M | 862k | 78.10 |
| 2014-06-30 | $55M | 868k | 63.20 |
| 2014-03-31 | $50M | 739k | 67.20 |
| 2013-12-31 | $48M | 742k | 64.31 |
| 2013-09-30 | $12M | 191k | 63.99 |